| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |